Currently, FGF21 has been widely used in the prevention and rehabilitation of metabolic diseases such as hepatic lipid and glycolipid metabolism as well as cardiovascular diseases, and it may become one of the effective targets for metabolic disease prevention and rehabilitation (47). This evidence concerns the gene FGF21 and cardiovascular disorder.